News
ABT
87.83
-0.66%
-0.58
Abbott Labs Price Target Maintained With a $115.00/Share by Piper Sandler
Dow Jones · 14h ago
Piper Sandler Reiterates Overweight on Abbott Laboratories, Maintains $115 Price Target
Benzinga · 15h ago
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
PR Newswire · 16h ago
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Abbott Laboratories (ABT) and AbbVie (ABBV)
TipRanks · 22h ago
Weekly Report: what happened at ABT last week (0615-0619)?
Weekly Report · 23h ago
Best Dividend Kings: June 2026
Seeking Alpha · 1d ago
Abbott Laboratories (ABT) Stock Could Be 24% Below Fair Value Before Earnings
Simply Wall St · 2d ago
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
The Motley Fool · 2d ago
Insider trades: American Express, Dell and Broadcom among notable names
Seeking Alpha · 2d ago
Enphase, Abbott, AmEx, Lowe’s, Bloom: Insider Shockwaves
TipRanks · 2d ago
3 Best Healthcare Stocks to Buy in June, According to Analysts
TipRanks · 3d ago
3 US Dividend Growth Stocks With Balance Sheet And Payout Focus
Simply Wall St · 3d ago
Top Abbott Insider Makes Bold Move With Fresh Share Purchase
TipRanks · 4d ago
Living Longer Is Big Business. These Stocks Will Benefit.
Barron‘s · 4d ago
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Abbott Laboratories (ABT)
TipRanks · 4d ago
The Hidden Winners Inside SCHD - June 2026 Breakdown
Seeking Alpha · 5d ago
Citi sum-of-the-parts analysis shows Abbott share upside
TipRanks · 5d ago
Edwards Lifesciences hits 52-week high after Medicare coverage proposal
Seeking Alpha · 6d ago
Edwards jumps after CMS proposes to expand TAVR coverage
TipRanks · 6d ago
Edwards best positioned to benefit from CMS proposal, says TD Cowen
TipRanks · 6d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.